FR2792836B3
(fr)
|
1999-04-30 |
2001-07-27 |
Sanofi Sa |
Composition pharmaceutique sous forme unitaire contenant de l'aspirine et de l'hydrogenosulfate de clopidogrel
|
CA2363053C
(en)
*
|
2001-11-09 |
2011-01-25 |
Bernard Charles Sherman |
Clopidogrel bisulfate tablet formulation
|
PT1467735E
(pt)
*
|
2001-12-18 |
2009-03-10 |
Teva Pharma |
Polimorfos de hidrogenossulfato de clopidogrel
|
US6767913B2
(en)
|
2001-12-18 |
2004-07-27 |
Teva Pharmaceutical Industries Ltd. |
Crystal forms iii, iv, v, and novel amorphous form of clopidogrel hydrogensulfate, processes for their preparation, processes for the preparation of form i, compositions containing the new forms and methods of administering the new forms
|
US7074928B2
(en)
|
2002-01-11 |
2006-07-11 |
Teva Pharmaceutical Industries, Ltd. |
Polymorphs of clopidogrel hydrogensulfate
|
HUP0200438A3
(en)
*
|
2002-02-06 |
2003-10-28 |
Egis Gyogyszergyar Nyilvanosan |
Novel clopidogrel hydrochloride polymorphs, process for the preparation thereof, their use and pharmaceutical compositions containing them
|
NZ535880A
(en)
|
2002-04-16 |
2007-11-30 |
Schering Corp |
Tricyclic thrombin receptor antagonists
|
ES2299720T3
(es)
*
|
2002-05-31 |
2008-06-01 |
Schering Corporation |
Formas polimorfas de un inhibidor de xantina-fosfodiesterasa v.
|
US6800759B2
(en)
|
2002-08-02 |
2004-10-05 |
Teva Pharmaceutical Industries Ltd. |
Racemization and enantiomer separation of clopidogrel
|
IL166593A0
(en)
|
2002-08-02 |
2006-01-15 |
|
Racemization and enantiomer separation of clopidogrel
|
CZ297472B6
(cs)
*
|
2002-08-27 |
2006-12-13 |
Zentiva, A.S. |
Zpusob výroby clopidogrelu hydrogensulfátu krystalické formy I
|
US20040067995A1
(en)
*
|
2002-10-02 |
2004-04-08 |
Wong Pancras C. |
Novel combination of a factor Xa inhibitor and clopidogrel
|
ITMI20022228A1
(it)
*
|
2002-10-21 |
2004-04-22 |
Dinamite Dipharma S P A |
Sali di clopidogrel con acidi alchil-solforici.
|
AU2003285841A1
(en)
*
|
2002-11-28 |
2004-06-18 |
Anpharm Przedsiebiorstwo Farmaceutyczne S.A. |
A process for the preparation of crystalline form 1 or clopidogrel hydrogen sulfate
|
DE10307343B4
(de)
*
|
2003-02-21 |
2005-10-06 |
Volkswagen Ag |
On-Board-Diagnosevorrichtung und On-Board-Diagnoseverfahren für Kraftfahrzeuge
|
WO2004081015A1
(en)
*
|
2003-03-10 |
2004-09-23 |
Hetero Drugs Limited |
Amorphous clopidogrel hydrogen sulfate
|
US7872019B2
(en)
*
|
2003-03-12 |
2011-01-18 |
Cadila Healthcare Limited |
Polymorphs and amorphous form of (S)-(+)-clopidogrel bisulfate
|
PL1618111T3
(pl)
*
|
2003-04-25 |
2015-06-30 |
Cadila Healthcare Ltd |
Sole klopidogrelu i sposób wytwarzania
|
EP1648903A2
(de)
|
2003-07-02 |
2006-04-26 |
Egis Gyogyszergyar Rt. |
Verfahren zur herstellung einer amorphen form eines die trombozytenaggregation hemmenden arzneimittels
|
US20070142637A1
(en)
*
|
2003-07-02 |
2007-06-21 |
Egis Gyogyszergyar Rt. |
Process for the preparation of crystalline polymorph of a platelet aggregation inhibitor drug
|
US7291735B2
(en)
*
|
2003-08-04 |
2007-11-06 |
The Company Of Wockhard Limited |
Process for the manufacture of (+)-(s)-clopidogrel bisulfate form-1
|
DE10337773A1
(de)
*
|
2003-08-13 |
2005-03-24 |
Krka Tovarna Zdravil, D.D. |
Kristallisation von festen Formen von Clopidogrel-Additionssalzen
|
GB0321256D0
(en)
*
|
2003-09-11 |
2003-10-08 |
Generics Uk Ltd |
Novel crystalline compounds
|
KR101110738B1
(ko)
*
|
2003-11-03 |
2012-02-17 |
카딜라 핼쓰캐어 리미티드 |
(s)-(+)-클로피도그렐 비설페이트의 상이한 형태의 제조 방법
|
CA2457459A1
(en)
*
|
2004-02-11 |
2005-08-11 |
Brantford Chemicals Inc. |
Resolution of racemates of methyl alpha-5-(4,5,6,7-tetrahydro(3,2-c)thienopyridyl)-(2-chlorophenyl) acetate
|
EP1720884A1
(de)
*
|
2004-02-24 |
2006-11-15 |
Siegfried Generics International AG |
Pharmakologisch akzeptierbare salze von clopidogrel
|
EP1772455A3
(de)
*
|
2004-03-05 |
2007-06-27 |
IPCA Laboratories Limited |
Verfahren zur Herstelung eines polymorphes von Clopidogrel Hydrogensulfat
|
AU2004318214B2
(en)
|
2004-04-09 |
2007-12-06 |
Hanmi Holdings Co., Ltd. |
Crystalline clopidogrel naphthalenesulfonate or hydrate thereof, method for preparing same and pharmaceutical composition containing same
|
EA010198B1
(ru)
*
|
2004-04-19 |
2008-06-30 |
Крка, Товарна Здравил, Д.Д., Ново Место |
Способы получения полиморфной формы i гидросульфата клопидогрела
|
KR20070012675A
(ko)
*
|
2004-04-20 |
2007-01-26 |
사노피-아벤티스 |
메틸(+)-(S)-α-(2-클로로페닐)-6,7-디히드로티에노[3,2-C]피리딘-5(4H) 아세테이트 히드로브로마이드, 클로피도그렐히드로브로마이드의 다형성 형태
|
ZA200608035B
(en)
*
|
2004-04-20 |
2008-07-30 |
Sanofi Aventis |
Clopidogrel salt and polymorphic forms thereof
|
US7829720B2
(en)
*
|
2004-05-04 |
2010-11-09 |
Bristol-Myers Squibb Company |
Process for preparing atazanavir bisulfate and novel forms
|
US20060154957A1
(en)
*
|
2004-09-21 |
2006-07-13 |
Nina Finkelstein |
Crystalline clopidogrel hydrobromide and processes for preparation thereof
|
US7446200B2
(en)
*
|
2004-10-04 |
2008-11-04 |
Usv, Ltd. |
Rapid resolution process of clopidogrel base and a process for preparation of clopidogrel bisulfate polymorph-form I
|
EP1848720A1
(de)
*
|
2005-02-15 |
2007-10-31 |
Usv Limited |
Schnelles verfahren zur optischen trennung von clopidogrel-base und verfahren zur herstellung der clopidogrelbisulfatpolymorphform i
|
EP1693375A1
(de)
*
|
2005-02-21 |
2006-08-23 |
KRKA, tovarna zdravil, d.d., Novo mesto |
Verfahren zur Herstellung von Clopidrogel hydrogen sulfat in Form I
|
EP1851231A2
(de)
*
|
2005-02-24 |
2007-11-07 |
Teva Pharmaceutical Industries Ltd |
Zur pharmazeutischen formulierung geeignete clopidogrel-basis und deren herstellung
|
US7772398B2
(en)
*
|
2005-03-11 |
2010-08-10 |
Dr. Reddy's Laboratories, Inc. |
Process for making crystalline form I of clopidogrel hydrogen sulphate
|
AU2006336417A1
(en)
*
|
2005-05-10 |
2007-08-02 |
Elan Pharma International, Limited |
Nanoparticulate clopidogrel formulations
|
KR20080016952A
(ko)
*
|
2005-06-13 |
2008-02-22 |
엘란 파마 인터내셔널 리미티드 |
나노입자형 클로피도그렐과 아스피린의 배합 제제
|
KR20070009851A
(ko)
*
|
2005-07-14 |
2007-01-19 |
씨제이 주식회사 |
클로피도그렐 황산수소염 함유 약학 조성물
|
WO2007052300A2
(en)
|
2005-09-05 |
2007-05-10 |
Cadila Healthcare Limited |
Processes for the preparation of different forms of (s)-(+)-clopidogrel besylate
|
EP1926736A4
(de)
*
|
2005-09-21 |
2010-08-25 |
Chong Kun Dang Pharm Corp |
Neuer resinat-komplex von s-clopidogrel und verfahren zu dessen herstellung
|
WO2007091253A2
(en)
*
|
2006-02-06 |
2007-08-16 |
C.T.S. Ltd. |
Pharmaceutical compositions comprising clopidogrel and vitamins which reduce homocysteine levels
|
US20070225320A1
(en)
*
|
2006-03-27 |
2007-09-27 |
Eswaraiah Sajja |
Process for preparing clopidogrel
|
WO2007113857A2
(en)
*
|
2006-04-05 |
2007-10-11 |
Cadila Healthcare Limited |
Modified release clopidogrel formulation
|
RU2008146758A
(ru)
*
|
2006-04-27 |
2010-06-10 |
Инд-Свифт Лэборетриз Лимитед (In) |
Способ получения полиморфных форм клопидогрела гидросульфата
|
JP2009539846A
(ja)
*
|
2006-06-06 |
2009-11-19 |
ブリストル−ミエルス スクイッブ カンパニー |
N−[5−[[[5−(1,1−ジメチルエチル)−2−オキサゾリル]メチル]チオ]−2−チアゾリル]−4−ピペリジンカルボキサミドの結晶形
|
US20090247569A1
(en)
*
|
2006-08-03 |
2009-10-01 |
Claude Singer |
Process for Preparing Clopidogrel Bisulphate
|
US8247558B2
(en)
*
|
2006-09-04 |
2012-08-21 |
Ranbaxy Laboratories Limited |
Process for the preparation of clopidogrel and its pharmaceutically acceptable salts
|
SI22383A
(sl)
*
|
2006-09-22 |
2008-04-30 |
Krka, Tovarna Zdravil, D.D., Novo Mesto |
Nov postopek sinteze klopidogrela in nove oblike njegovih farmacevtsko sprejemljivih soli
|
WO2008060934A2
(en)
*
|
2006-11-14 |
2008-05-22 |
Acusphere, Inc. |
Formulations of tetrahydropyridine antiplatelet agents for parenteral or oral administration
|
KR20080055356A
(ko)
*
|
2006-12-15 |
2008-06-19 |
에스케이케미칼주식회사 |
보관안정성이 우수한 클로피도그렐 함유 포접 복합체
|
EP2120879A2
(de)
*
|
2006-12-22 |
2009-11-25 |
Schering Corporation |
Desintegrationspromoter in nassgranulat-formulierungen mit fester dosierung
|
WO2008093357A2
(en)
*
|
2007-01-29 |
2008-08-07 |
Ipca Laboratories Limited |
Process for preparation of crystalline clopidogrel hydrogen sulphate form i
|
EP1970054A3
(de)
|
2007-03-14 |
2009-06-03 |
Ranbaxy Laboratories Limited |
Clopidogrel-Tabletten
|
PL382055A1
(pl)
*
|
2007-03-23 |
2008-09-29 |
Koźluk Tomasz Nobilus Ent |
Sposób wytwarzania formy krystalicznej 1 wodorosiarczanu klopidogrelu
|
ES2855700T3
(es)
|
2007-04-27 |
2021-09-24 |
Cydex Pharmaceuticals Inc |
Formulaciones que contienen clopidogrel y sulfoalquil éter-ciclodextrina y métodos de uso
|
WO2009080469A1
(en)
*
|
2007-12-24 |
2009-07-02 |
Sandoz Ag |
Process for the preparation of clopidogrel bisulphate form i
|
PT2095815E
(pt)
*
|
2008-02-26 |
2012-02-03 |
Lesvi Laboratorios Sl |
Formulações farmacêuticas contendo clopidogrel
|
EP2107061A1
(de)
|
2008-04-02 |
2009-10-07 |
Krka Tovarna Zdravil, D.D., Novo Mesto |
Herstellungsverfahren für optisch angereichertes Clopidogrel
|
US20090264460A1
(en)
*
|
2008-04-21 |
2009-10-22 |
Mamta Mishra |
Clopidogrel pharmaceutical formulations
|
CA2758322C
(en)
|
2009-04-10 |
2019-04-02 |
Tufts Medical Center, Inc. |
Par-1 activation by metalloproteinase-1 (mmp-1)
|
HUE047755T2
(hu)
|
2009-05-13 |
2020-05-28 |
Cydex Pharmaceuticals Inc |
Prasugrelt és ciklodextrin-származékokat tartalmazó gyógyszerkészítmények, eljárás ezek elõállítására és alkalmazásra
|
WO2011010318A1
(en)
*
|
2009-07-23 |
2011-01-27 |
Praveen Laboratories Private Limited |
Process for the preparation of clopidogrel polymorphous form 1 using seed chrystals
|
WO2011042804A2
(en)
|
2009-10-08 |
2011-04-14 |
Jubliant Life Sciences Limited |
An improved process for the preparation of clopidogrel hydrogen sulfate form i
|
KR101130445B1
(ko)
*
|
2009-10-29 |
2012-03-27 |
동아제약주식회사 |
클로피도그랠 황산수소염 ⅰ형 제조방법
|
WO2011051976A2
(en)
|
2009-10-30 |
2011-05-05 |
Matrix Laboratories Ltd |
An improved process for the preparation of clopidogrel bisulfate form i
|
CN101766573B
(zh)
|
2010-02-05 |
2013-02-13 |
上海安必生制药技术有限公司 |
硫酸氢氯吡格雷固体制剂的制备工艺
|
WO2011125069A1
(en)
|
2010-03-22 |
2011-10-13 |
Rpg Life Sciences Limited |
A process for preparation of crystalline form i of clopidogrel bisulfate
|
WO2011132201A1
(en)
|
2010-04-19 |
2011-10-27 |
Cadila Healthcare Limited |
A pharmaceutical composition comprising antiplatelet agents and an erythropoiesis stimulating agent
|
MX344435B
(es)
|
2011-06-27 |
2016-12-14 |
Ipca Laboratories Ltd * |
Compuestos antitromboticos.
|
KR101324862B1
(ko)
*
|
2011-07-12 |
2013-11-01 |
(주)에이에스텍 |
클로피도그렐 황산수소염의 구형 입자, 이를 포함하는 약학적 조성물 및 이의 제조방법
|
CN102367257B
(zh)
*
|
2011-11-21 |
2014-05-07 |
天津红日药业股份有限公司 |
氯吡格雷盐酸盐的单晶晶型,它们的制备及应用
|
WO2014118802A1
(en)
|
2013-01-31 |
2014-08-07 |
Pharmazell Gmbh |
An improved process for the preparation of clopidogrel bisulfate form-i
|
JP5905165B2
(ja)
|
2013-08-02 |
2016-04-20 |
サノフイ |
アセチルサリチル酸およびクロピドグレルを含む医薬錠剤
|
CN103524528A
(zh)
*
|
2013-09-16 |
2014-01-22 |
吉林省博大伟业制药有限公司 |
一种改进的ⅱ型硫酸氢氯吡格雷结晶制备方法
|
HUP1400294A2
(hu)
|
2014-06-13 |
2015-12-28 |
Skillpharm Kft |
Clopidogrel új alkalmazása
|
KR101710922B1
(ko)
|
2015-06-03 |
2017-02-28 |
경동제약 주식회사 |
클로피도그렐 황산염 결정형 i형의 제조방법
|
CN107698620A
(zh)
|
2015-06-23 |
2018-02-16 |
江苏天士力帝益药业有限公司 |
一种氘代噻吩并哌啶衍生物、制备方法及其应用
|
KR102139346B1
(ko)
|
2017-01-23 |
2020-07-29 |
동화약품주식회사 |
HMG-CoA 환원효소 억제제 및 클로피도그렐을 포함하는 복합제제
|
CN107163060B
(zh)
*
|
2017-05-24 |
2021-03-02 |
常州制药厂有限公司 |
一种硫酸氢氯吡格雷晶型ii制备方法
|
CN107337683B
(zh)
*
|
2017-08-16 |
2019-08-16 |
中荣凯特(北京)生物科技有限公司 |
一种噻吩并吡啶类衍生物硫酸氢盐的晶型ⅱ及其制备方法和应用
|
CN109438467B
(zh)
*
|
2018-11-14 |
2021-03-26 |
四川青木制药有限公司 |
一种硫酸氢氯吡格雷ⅱ型球形结晶的制备方法
|
WO2023012479A1
(en)
|
2021-08-03 |
2023-02-09 |
Liqmeds Worldwide Limited |
An oral pharmaceutical solution of clopidogrel
|